Related Experiment Video
Updated: Jul 16, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Paediatric health economic evaluations: a world view
Healthcare Quarterly (Toronto, Ont.)
|March 1, 2007
Summary
Paediatric health economic evaluations have increased, focusing on prevention. Developing nations need more local research, highlighting a gap in data transfer and the need for long-term effect measurement tools.
Area of Science:
- Health Economics
- Paediatric Research
- Global Health
Background:
- Economic evaluation methods are evolving, with increased scrutiny on their application to children.
- Paediatric health economic evaluations have not kept pace with general economic evaluations.
Purpose of the Study:
- To review paediatric health economic evaluations from the last 25 years.
- To identify trends, disparities between developed and developing nations, and future research needs.
Main Methods:
- Utilized data from the Paediatric Economic Database Evaluation (PEDE) project up to 2003.
- Analyzed temporal and geographic trends, intervention categories, and conditions studied.
Main Results:
- A rapid increase in paediatric health economic evaluations since 1980.
- Infective diseases, congenital anomalies, and pregnancy complications were most studied; prevention was emphasized over treatment.
- The US and UK dominated publications; developing nations produced few evaluations despite high need. Local priorities influenced study topics (e.g., HIV/malaria in developing nations, asthma/birth defects in developed nations).
Conclusions:
- Developing nations depend on foreign research, indicating a need for improved data transfer and extrapolation methods.
- Future research should prioritize paediatric cost-consequence models and tools for measuring long-term effects.
Related Concept Videos
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:30Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...